Does ANAMORELIN Cause Malignant neoplasm progression? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Malignant neoplasm progression have been filed in association with ANAMORELIN. This represents 21.5% of all adverse event reports for ANAMORELIN.
28
Reports of Malignant neoplasm progression with ANAMORELIN
21.5%
of all ANAMORELIN reports
21
Deaths
16
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ANAMORELIN?
Of the 28 reports, 21 (75.0%) resulted in death, 16 (57.1%) required hospitalization, and 6 (21.4%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAMORELIN. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does ANAMORELIN Cause?
Decreased appetite (14)
Interstitial lung disease (13)
Oedema peripheral (9)
Pyrexia (9)
Non-small cell lung cancer (8)
Anaemia (7)
Hyperglycaemia (6)
Hypothyroidism (6)
Nausea (6)
Platelet count decreased (6)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ANAMORELIN Alternatives Have Lower Malignant neoplasm progression Risk?
ANAMORELIN vs ANASTROZOLE
ANAMORELIN vs ANDEXANET ALFA
ANAMORELIN vs ANDROGEL
ANAMORELIN vs ANETHOLTRITHION
ANAMORELIN vs ANGIOTENSIN II